arrow
S

Sofía D. Merajver

University of Michigan Medical School
H指数:79
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Saturation mutagenesis enables RAD51D clinical variant interpretation and identifies distinct biochemical functions

饱和诱变有助于RAD51D临床变异的解释并识别不同的生化功能

2026-10-030
OA
TLSB-17 BREAST CANCER BRAIN METASTASES REQUIRE INTERLEUKIN-34 FOR METASTATIC GROWTH

TLSB-17 乳腺癌脑转移需要白细胞介素-34以实现转移性生长

2026-08-070
OA
Matrix Composition Modulates Cancer Cell Phenotypes and Secretions in a Blood–Brain Barrier Organ-on-a-Chip Model: Comparison of Collagen and Hyaluronic Acid

基质组成调节癌症细胞表型和分泌物的血脑屏障器官芯片模型:胶原蛋白与透明质酸的对比

2026-04-150
PRE
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026 Featured Updates to the NCCN Guidelines

陈, H.H.; 吉里, V.N.; 戈根斯, M.; 尤尔格伦, M.B.; 卡兰, B.Y.; 诺奎斯特, B.S.; 戴利, M.B.; 帕尔, T.; 阿利利, Z.; 阿伦, B.; 等. NCCN指南(R)要点:遗传/家族高风险评估:乳腺、卵巢、胰腺和前列腺,版本2.2026. J. Natl. Compr. Cancer Netw. 2026, 24, 2–10. [Google Scholar] [CrossRef] [PubMed]

2026-02-013
PRE
PRECISION ONCOLOGY FOR HIGH-GRADE GLIOMAS: A TUMOR ORGANOID PLATFORM FOR RAPID, PATIENT-SPECIFIC DRUG SCREENING

高分级胶质瘤的精准肿瘤学:一种用于快速、患者特异性药物筛选的肿瘤类器官平台

2025-11-010
OAAI
Patient-derived tumor-oids recapitulate the tumor microenvironment and allow for pre-clinical drug screening across the entire spectrum of pediatric brain tumors

患者来源的类器官能够重现肿瘤微环境,并允许对整个谱系的儿童脑肿瘤进行临床前药物筛选。

2025-11-010
OAAI
Combinatorial targeting of avapritinib-driven MAPK activation in pediatric high-grade glioma

阿伐普利尼布诱导的MAPK激活在儿童高级别胶质瘤中的组合靶向治疗

2025-11-010
OAAI
Precision Oncology for High-Grade Gliomas: A Tumor Organoid Model for Adjuvant Treatment Selection

高分级胶质瘤的精准肿瘤学:一种用于辅助治疗选择的肿瘤类器官模型

2025-10-190
OAAI
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
2025-01-240
OAAI